Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J)
2006

Comparing Blood Pressure Treatments in Diabetic Patients

Sample size: 300 publication Evidence: moderate

Author Information

Author(s): Ryuzo Kawamori, Hiroyuki Daida, Yasushi Tanaka, Katsumi Miyauchi, Akira Kitagawa, Dobun Hayashi, Junji Kishimoto, Shunya Ikeda, Yutaka Imai, Tsutomu Yamazaki

Primary Institution: Juntendo University School of Medicine

Hypothesis

Is increasing the dose of angiotensin II antagonists more effective than adding amlodipine for controlling blood pressure in diabetic patients?

Conclusion

The ADVANCED-J study aims to determine the best method for controlling blood pressure in diabetic patients who are inadequately managed with current treatments.

Supporting Evidence

  • Diabetes and hypertension together increase cardiovascular disease risk.
  • Blood pressure control is crucial for preventing complications in diabetic patients.
  • Home blood pressure monitoring can reveal masked hypertension.

Takeaway

This study is trying to find out if giving more of one type of blood pressure medicine or adding another type works better for people with diabetes.

Methodology

A multi-center, prospective, randomized, open label, blinded-endpoint trial comparing two treatment strategies in hypertensive patients with diabetes.

Potential Biases

Potential selection bias in patient recruitment and reporting bias in self-measured blood pressure.

Limitations

The study may not account for all variables affecting blood pressure control, and results may not be generalizable to all populations.

Participant Demographics

Hypertensive patients aged 20 years or older with type 2 diabetes mellitus.

Digital Object Identifier (DOI)

10.1186/1471-2261-6-39

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication